Biophytis S.A. Files Form 6-K
| Field | Detail |
|---|---|
| Company | Biophytis SA |
| Form Type | 6-K |
| Filed Date | Oct 14, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, administrative
Related Tickers: BPTS
TL;DR
Biophytis (BPTS) filed a 6-K, just an admin update, no news.
AI Summary
Biophytis S.A. filed a Form 6-K on October 13, 2025, reporting its status as a foreign private issuer. The filing provides basic company information and its principal executive office address in Paris, France. No specific financial or operational updates were detailed in this particular filing.
Why It Matters
This filing is a routine administrative update for Biophytis S.A. as a foreign private issuer, indicating no new material events or financial disclosures at this time.
Risk Assessment
Risk Level: low — This filing is a standard administrative report and does not contain new material information that would typically impact risk.
Key Players & Entities
- Biophytis S.A. (company) — Registrant
- Stanislas Veillet (person) — Contact Person
- 001-38974 (company) — SEC File Number
- October 13, 2025 (date) — Report Date
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer filed by Biophytis S.A. pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Who is the filer of this report?
The filer is Biophytis S.A., a foreign private issuer.
What is the date of this report?
The date of the report is October 13, 2025.
Where is Biophytis S.A.'s principal executive office located?
Biophytis S.A.'s principal executive office is located at Sorbonne University—BC 9, Bâtiment A 4ème étage, 4 place Jussieu, 75005 Paris, France.
Does Biophytis S.A. file annual reports under Form 20-F or 40-F?
The filing indicates that Biophytis S.A. files annual reports under cover of Form 20-F.
Filing Stats: 253 words · 1 min read · ~1 pages · Grade level 10.3 · Accepted 2025-10-14 06:08:52
Filing Documents
- tm2528617d1_6k.htm (6-K) — 10KB
- tm2528617d1_ex99-1.htm (EX-99.1) — 20KB
- tm2528617d1_ex99-1img001.jpg (GRAPHIC) — 16KB
- 0001104659-25-098896.txt ( ) — 53KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BIOPHYTIS S.A. Date: October 13, 2025 By: /s/ Stanislas Veillet Name: Stanislas Veillet Title: Chairman and Chief Executive Officer